NCT06149000View on ClinicalTrials.gov

Migraine Headache Mitigation Utilizing Avulux

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

June 13, 2024

Study Completion Date

June 20, 2024

Conditions
MigraineHeadachePhotophobia
Interventions
DEVICE

Avulux Lenses

Avulux lenses are specialized eyewear designed to reduce specific wavelengths of light to alleviate symptoms in individuals who experience light sensitivity and migraines

DEVICE

Placebo Lenses

Lenses that will look identical to Avulux lenses without the medical benefits

All Listed Sponsors
lead

Kaiser Permanente

OTHER

NCT06149000 - Migraine Headache Mitigation Utilizing Avulux | Biotech Hunter | Biotech Hunter